Fractyl Laboratories Garners $57,000,000 Series C Funding Round

  • Feed Type
  • Date
    11/19/2015
  • Company Name
    Fractyl Laboratories
  • Mailing Address
    203 Crescent St. Waltham, MA 02453 USA
  • Company Description
    To liberate patients, empower physicians, and lower health care costs by developing device-based solutions to chronic diseases.
  • Website
    http://www.fractyl.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $57,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    We will use these funds to accelerate our clinical development as we expedite our path to market. To this end, we have already treated 28 patients in our first international multicenter clinical trial and remain on track to begin randomized studies next year.
  • M&A Terms
  • Venture Investor
    Deerfield Capital
  • Venture Investor
    Mithril Capital Management
  • Venture Investor
    General Catalyst Partners
  • Venture Investor
    Bessemer Venture Partners
  • Venture Investor
    Domain Associates

Trending on Xconomy